In conclusion, further research is necessary to elucidate the potential roles of PXR and CAR in the development and progression of NAFLD/NASH, as well as to determine their temporal functions in the various stages of this complex disease. This evidence concerns the gene NR1I3 and metabolic dysfunction-associated steatotic liver disease.